Platelet-Rich Plasma Versus Autologous Whole Blood for the Treatment of Chronic Lateral Elbow Epicondylitis

American Journal of Sports Medicine - Tập 39 Số 10 - Trang 2130-2134 - 2011
C. Thanasas1, George N. Papadimitriou2, Charalambos Charalambidis2, I. Paraskevopoulos2, Athanasios Papanikolaou2
1Henry Dunant Hospital, Athens, Greece
2Red Cross Hospital, Athens, Greece

Tóm tắt

Background: Chronic lateral elbow epicondylitis is a tendinosis with angiofibrolastic degeneration of the wrist extensors’ origin. Healing of this lesion is reported with the use of autologous blood as well as with platelet-rich plasma (PRP). Purpose: A comparative study of these 2 treatments was conducted in an effort to investigate the possible advantages of PRP. Study Design: Randomized controlled trial; Level of evidence, 1. Methods: Twenty-eight patients were divided equally into 2 groups, after blocked randomization. Group A was treated with a single injection of 3 mL of autologous blood and group B with 3 mL of PRP under ultrasound guidance. A standardized program of eccentric muscle strengthening was followed by all patients in both groups. Evaluation using a pain visual analog scale (VAS) and Liverpool elbow score was performed at 6 weeks, 3 months, and 6 months. Results: The VAS score improvement was larger in group B at every follow-up interval but the difference was statistically significant only at 6 weeks, when mean improvement was 3.8 points (95% confidence interval [CI], 3.1-4.5) in group B (61.47% improvement) and 2.5 points (95% CI, 1.9-3.1) in group A (41.6% improvement) ( P < .05). No statistically significant difference was noted between groups regarding Liverpool elbow score. Conclusion: Regarding pain reduction, PRP treatment seems to be an effective treatment for chronic lateral elbow epicondylitis and superior to autologous blood in the short term. Defining details of indications, best PRP concentration, number and time of injections, as well as rehabilitation protocol might increase the method’s effectiveness. Additionally, the possibility of cost reduction of the method might justify the use of PRP over autologous whole blood for chronic or refractory tennis elbow.

Từ khóa


Tài liệu tham khảo

10.1016/j.orthres.2004.08.015

10.1097/01.prs.0000255543.43695.1d

10.1080/00016470410001708190

Biomet. GPS II system. http://www.biomet.com/biologics/information/pdf/Y-BMT-991.pdf. Accessed June 30, 2011.

10.2106/00004623-198668050-00005

10.1007/s00256-006-0081-9

10.1136/bjsm.2006.033324

10.1177/0363546508314430

10.1053/jhsu.2003.50041

10.1097/01.PRS.0000138251.07040.51

10.1177/0363546509349921

10.5435/00124635-200910000-00002

10.1016/j.jbspin.2003.05.002

10.1002/jcp.21368

10.1016/j.orthres.2005.01.014.1100230627

10.1002/sim.4780110811

10.1016/S0142-9612(03)00114-5

10.1007/s00264-009-0728-y

10.1016/j.joms.2003.12.003

10.1097/00008505-200110000-00002

10.1016/j.pmrj.2009.02.010

10.1177/0363546506288850

10.1016/S0278-5919(20)30489-0

10.2106/00004623-197961060-00005

10.1177/0363546509355445

10.1093/rheumatology/keh367

10.1093/rheumatology/33.12.1166

10.1080/17453670610013033

VuMedi. http://www.vumedi.com/webinars/PRP. Accessed June 30, 2011.

10.1097/01.blo.0000195927.81845.46

Woodall J, 2008, Biomed Sci Instrum, 44, 489

Woodall J, 2007, Biomed Sci Instrum, 43, 266

Thông tin
Thông tin xuất bản

American Journal of Sports Medicine

Tập 39 Số 10

2130-2134

Thông tin tác giả